Sulfonamide desensitization in solid organ transplant recipients: A protocol-driven approach during the index transplant hospitalization

Joseph B. Pryor, Ali J. Olyaei, Denise Kirsch, Lynne Strasfeld

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Trimethoprim-sulfamethoxazole (TMP-SMX) is the first-line agent for Pneumocystis jiroveci pneumonia (PJP) prophylaxis for solid organ transplant (SOT) recipients because of its efficacy for this indication, extended antimicrobial coverage, and favorable cost. Reported sulfonamide allergy is not uncommon and often results in TMP-SMX avoidance. Desensitization offers an efficacious and cost-effective alternative to TMP-SMX avoidance. Herein, we reviewed our experience with desensitization during the index transplant hospitalization among 52 SOT recipients with history of a non-anaphylactic sulfonamide allergy. Of those enrolled in the desensitization protocol, 92% (48/52) completed the protocol, with nearly 80% (41/52) still on TMP-SMX at 3 months without adverse reaction. Eleven patients discontinued TMP-SMX (7 for allergic reactions and 4 for non-allergic reasons) and switched to pentamidine. A cost savings of $575 per desensitization was calculated based on annual wholesale drug prices, for a total savings of $23 575. Additionally, the protocol did not delay discharge in any patient nor was it associated with any severe allergic reactions. These findings suggest TMP-SMX desensitization is safe and effective in SOT recipients with a history of non-anaphylactic, non-life-threatening sulfonamide hypersensitivity.

Original languageEnglish (US)
Article numbere13191
JournalTransplant Infectious Disease
Volume21
Issue number6
DOIs
StatePublished - Dec 1 2019

Keywords

  • desensitization
  • hypersensitivity
  • pneumocystis
  • post-transplant
  • sulfa
  • sulfonamide

ASJC Scopus subject areas

  • Infectious Diseases
  • Transplantation

Fingerprint Dive into the research topics of 'Sulfonamide desensitization in solid organ transplant recipients: A protocol-driven approach during the index transplant hospitalization'. Together they form a unique fingerprint.

Cite this